Clin2
NCT03936361Possibly a fitRecruiting

Statins after a stroke bleed in the brain (Phase 3)

Intracerebral Hemorrhage

Part of Brain & nervous system, Heart & circulation clinical trials.

This trial studies whether continuing or stopping statin medicine after a spontaneous bleeding stroke in the brain (called lobar ICH) leads to better outcomes. It may help clarify if statins are safer to stay on—or better to pause—after this type of event.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
1,456 people
Ages
50 years and older
Study type
Interventional

Who can take part

  • You are age 50 or older
  • Your CT or MRI showed a spontaneous bleeding stroke in the brain’s lobar area
  • You were taking a statin when the bleeding stroke started
  • You can start the trial within 7 days of the bleed
  • Your statin prescriber and you (or a legal representative) agree you can choose to continue or stop the statin for the study

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07088250Recruiting
Statins for Treating Brain Bleeding

This trial tests if the statin drug atorvastatin can help people recover from a type of stroke called a brain bleed. It is for adults who have a moderate-sized bleed in the upper part of the brain and can start taking the drug within 48 hours of symptoms.

Anqing, Anhui
NCT07344610Recruiting
Short-term high-dose statin therapy after stroke

This trial tests whether starting a high dose of a statin (a cholesterol-lowering medicine) soon after a stroke can improve your cholesterol levels. It is for people who have had a stroke or have significant narrowing of arteries in the brain or neck.

Shenyang, Liaoning
NCT03753555Recruiting· Phase 4
High-intensity statin treatment for certain stroke artery plaque cases

This trial tests whether a higher-dose statin can help after an ischemic stroke in people who have specific plaque patterns in brain blood vessels. It may help lower the risk of another stroke by targeting the artery plaque process.

Shenyang
NCT06785727Not yet recruiting· Phase 4
Statin Use in Frail Older Stroke Patients

This study tests whether starting a statin soon after a stroke or mini-stroke helps older adults (70+) who are frail. You will be randomly assigned to receive a statin or a placebo to see if it reduces the chance of another stroke.

NCT07256171Not yet recruiting
Cholesterol after stroke: doing better

This study is for people who recently had a stroke or TIA and have high cholesterol. It aims to see how well different cholesterol-lowering treatments work to prevent another stroke.

NCT06559072Not yet recruiting· Phase 3
Early statin for brain aneurysm bleeding

This trial tests whether giving a statin medication very early (within 6 hours of symptoms) can improve recovery after a brain aneurysm bleed. It aims to see if early treatment helps protect the brain.

Tianjin

Hear when a new Intracerebral Hemorrhage trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.